期刊
JOURNAL OF NEUROCHEMISTRY
卷 85, 期 5, 页码 1101-1108出版社
WILEY
DOI: 10.1046/j.1471-4159.2003.01654.x
关键词
Alzheimer; beta-amyloid; dementia; melatonin; oxidative stress; protein nitration
资金
- NIA NIH HHS [R01 AG16783-04] Funding Source: Medline
Increased levels of a 40-42 amino-acid peptide called the amyloid beta protein (Abeta) and evidence of oxidative damage are early neuropathological markers of Alzheimer's disease (AD). Previous investigations have demonstrated that melatonin is decreased during the aging process and that patients with AD have more profound reductions of this hormone. It has also been recently shown that melatonin protects neuronal cells from Abeta-mediated oxidative damage and inhibits the formation of amyloid fibrils in vitro . However, a direct relationship between melatonin and the biochemical pathology of AD had not been demonstrated. We used a transgenic mouse model of Alzheimer's amyloidosis and monitored over time the effects of administering melatonin on brain levels of Abeta, abnormal protein nitration, and survival of the mice. We report here that administration of melatonin partially inhibited the expected time-dependent elevation of beta-amyloid, reduced abnormal nitration of proteins, and increased survival in the treated transgenic mice. These findings may bear relevance to the pathogenesis and therapy of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据